Filters
Use basic filters below or open advanced options for more precise results.
Last dataset refresh: 20 Jun 2026
| Product name | Classification | Strength | Form | Manufacturer | Country of origin | Status | Registered On | Action | |
|---|---|---|---|---|---|---|---|---|---|
|
Tafinlar® 50 mg
|
Conventional Medicines | 50 mg/Capsule | Capsule | Novartis Pharmaceutical Manufacturing LLC , Slovenia, 1000 Ljubljana | Ireland | Active | 30 Jun 2022 | View details → | |
|
Tafinlar® 75 mg
|
Conventional Medicines | 75 mg/Capsule | Capsule | Novartis Pharmaceutical Manufacturing LLC , Slovenia, 1000 Ljubljana | Ireland | Active | 30 Jun 2022 | View details → | |
|
Tafinlar® 75 mg
|
Conventional Medicines | 75 mg/Capsule | Capsule | Novartis Pharmaceutical Manufacturing LLC , Slovenia, 1000 Ljubljana | Ireland | Active | 30 Jun 2022 | View details → | |
|
Tafixyl 100 mg/ml; 10 ml
|
Conventional Medicines | 100 mg/ml | Injection | INDUSTRIA FARMACEUTICA GALENICA SENESE S.r.l, Italy, Monteroni D'Arabia | Portugal | Active | 27 Aug 2015 | View details → | |
|
Tafixyl 100 mg/ml; 10 ml
|
Conventional Medicines | 100 mg/ml | Injection | INDUSTRIA FARMACEUTICA GALENICA SENESE S.r.l, Italy, Monteroni D'Arabia | Portugal | Active | 27 Aug 2015 | View details → | |
|
Tafixyl 100 mg/ml; 5 ml
|
Conventional Medicines | 100 mg/ml | Injection | INDUSTRIA FARMACEUTICA GALENICA SENESE S.r.l, Italy, Monteroni D'Arabia | Portugal | Active | 27 Aug 2015 | View details → | |
|
Tafixyl 100 mg/ml; 5 ml
|
Conventional Medicines | 100 mg/ml | Injection | INDUSTRIA FARMACEUTICA GALENICA SENESE S.r.l, Italy, Monteroni D'Arabia | Portugal | Active | 27 Aug 2015 | View details → | |
|
Tafixyl™ 500mg
|
Conventional Medicines | 500 mg/tablet | Tablet | LABIANA PHARMACEUTICALS, SLU, Spain, Barcelona | Portugal | Active | 08 Jun 2017 | View details → | |
|
TAGARA CAPSULES
|
Natural Source Medicines | 250mg | Capsule | HIMALAYA WELLNESS COMPANY, India, Bengaluru | India | Active | 23 May 2017 | View details → | |
|
Tagara Tablets (Himalaya)
|
Natural Source Medicines | 250 mg | Tablet | HIMALAYA WELLNESS COMPANY, India, Bengaluru | India | Active | 24 Aug 2022 | View details → | |
|
TAGRISSO™ 40 mg
|
Conventional Medicines | 40 mg/tablet | Tablet | AstraZeneca AB., Sweden, Sodertalje | Sweden | Active | 12 May 2016 | View details → | |
|
TAGRISSO™ 80 mg
|
Conventional Medicines | 80 mg/tablet | Tablet | AstraZeneca AB., Sweden, Sodertalje | Sweden | Active | 12 May 2016 | View details → | |
|
TAKEPRON® 15mg
|
Conventional Medicines | 15mg / Capsule | Capsule | THE ARAB PHARMACEUTICAL MANUFACTURING PSC, Jordan, Sult | Jordan | Active | 04 Jul 1999 | View details → | |
|
TAKEPRON® 30mg
|
Conventional Medicines | 30mg/ Capsule | Capsule | THE ARAB PHARMACEUTICAL MANUFACTURING PSC, Jordan, Sult | Jordan | Active | 29 Dec 1997 | View details → | |
|
TAKHZYRO® 150 mg
|
Biological Medicines | 150 mg / 1ml | Injection | Takeda Pharmaceuticals International AG Ireland Branch, Ireland, Dublin 2 | Ireland | Active | 21 Jun 2024 | View details → | |
|
TAKHZYRO™ 300 mg
|
Biological Medicines | 300 mg/ 2 ml | Injection | Takeda Pharmaceuticals International AG Ireland Branch, Ireland, Dublin 2 | Ireland | Active | 10 Feb 2022 | View details → | |
|
Talekt Tablets
|
Natural Source Medicines | Combination | Tablet | HIMALAYA WELLNESS COMPANY, India, Bengaluru | India | Active | 27 Dec 2020 | View details → | |
|
Talicia®
|
Conventional Medicines | Combination | Capsule | GLOBALPHARMA CO. LLC., United Arab Emirates, Dubai | United Arab Emirates | Active | 03 Oct 2022 | View details → | |
|
taltz™ 80 mg/mL
|
Biological Medicines | 80 mg/ml | Injection | ELI LILLY AND COMPANY, United States of America, INDIANAPOLIS | United States of America | Active | 29 Sep 2016 | View details → | |
|
TALVEY® 2 mg/mL
|
Biological Medicines | 3mg/1.5ml | Injection | JANSSEN PHARMACEUTICA NV, BELGIUM, Beerse | BELGIUM | Active | 29 Mar 2024 | View details → | |
|
TALVEY® 40 mg/mL
|
Biological Medicines | 40mg/ml | Injection | JANSSEN PHARMACEUTICA NV, BELGIUM, Beerse | BELGIUM | Active | 29 Mar 2024 | View details → | |
|
Talzenna® 0.1mg
|
Conventional Medicines | 0.1 mg/Capsule | Capsule | SHARP CORPORATION (d/b/a Sharp Packaging Solutions), United States of America, Allentown | United States of America | Active | 13 Dec 2023 | View details → | |
|
Talzenna® 0.25 mg
|
Conventional Medicines | 0.25 mg | Capsule | Viatris Pharmaceuticals L.L.C., United States of America, Vega Baja, Puerto Rico | United States of America | Active | 17 Mar 2019 | View details → | |
|
Talzenna® 0.35 mg
|
Conventional Medicines | 0.35 mg/capsule | Capsule | SHARP CORPORATION (d/b/a Sharp Packaging Solutions), United States of America, Allentown | United States of America | Active | 13 Dec 2023 | View details → |
Compare selected products
0 of 3 selected